Human Factors/Usability Studies Following ISO 62366 and the New FDA Guidance - Webinar - ResearchAndMarkets.com
2022-12-02
DUBLIN--(BUSINESS WIRE)--The "Human Factors/Usability Studies following ISO 62366 and the new FDA Guidance" webinar has been added to ResearchAndMarkets.com's offering.
'Human Factors/Usability Studies following ISO 62366 and the new FDA Guidance'
The FDA will only approve devices which are designed so that it is practically impossible for people to accidentally harm themselves even if they use the device improperly. The FDA has replaced the term "user error" with "use error".
This means that use error is considered by the FDA to be a device nonconformity because human factors should be considered in the design process. The burden is on the device designer to create an "idiot proof" product.
Who Should Attend:
Engineering management
Quality assurance
Key Topics Covered:
User error versus use error
Use related hazards and risk analysis
User profiles
Use scenarios
Step by step human factors program development
Validation
For more information about this webinar visit https://www.researchandmarkets.com/r/p6ange
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
-靶点
-药物
-来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。